Annandale facility seeks volunteers for a clinical trail on an HIV vaccine
CARE-ID is one of 20 facilities in the United States participating in HVTN 505 study to determine the effectiveness of a vaccine that has shown promise in previous studies. The trial is being coordinated by the HIV Vaccine Trials Network.
To be eligible for the study, volunteers must be men who have sex with men or “transwomen” (male to female transgendered individuals) who have sex with men and must be age 18-50, circumcised, HIV negative, and in good general health. The vaccines do not contain the HIV virus and cannot cause HIV infection.
According to Hope Takes Action, “Every 10 minutes, someone in the United States is infected with HIV. A preventive vaccine against HIV offers the best long-term hope to end this worldwide epidemic.”
To sign up online, visit the CARE-ID website.
